Seba Saleh Nadeef

Dr. Seba Nadeef holds a bachelor’s degree in Biotechnology from the University of Taif. She earned her MS-PhD in Biological and Environmental Science (2019) from KAUST, completed through a gifted partnership with the University of California, Irvine. She conducted postdoctoral research as a Fellow at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), focusing on advanced biomedical and translational research.

She began working as an Associate Scientist in the Center of Genomic Medicine at KFSHRC in 2022, and has since joined Innovation & Research in bioengineering and nanomedicine labs. Her current research focuses on identifying predictive biomarkers in autoimmune disease and various cancers, with the aim of developing molecular diagnostic panels that are highly sensitive and cost-effective, leading to personalised treatment and early detection.

Beyond her research track, she is actively engaged in supporting research activities and strengthening academic-industry partnerships. This is reinforced through formal training and professional development, including Entrepreneurship Essentials and Negotiation Mastery courses earned at Harvard Business School. She was a member of the MIT Biotech Consulting Group and is a member of the advisory committee at the Saudi Food and Drug Authority (SFDA) and the U.S. Exchange Alumni Program in Riyadh.

Genomics

Epigenetics

Next-Generation Sequencing (NGS)

Biomarker discovery

Diagnostics

Dr. Seba Nadeef completed her MS in Biological Sciences at KAUST in 2014. During her master’s, she conducted research at the Children’s National Hospital, focusing on biomarker development for Duchenne Muscular Dystrophy. She received a KAUST PhD scholarship to pursue doctoral studies at UC Irvine, where she contributed to multidisciplinary projects in the Department of Developmental Biology and the Center for Metabolism, leading to publications in high-impact journals.

Her research was focused on Polycomb group proteins in muscle metabolism and circadian regulation, linking circadian biology, gene regulation, and metabolic disorders such as obesity. She received the prestigious Ibn Khaldun Fellowship for postdoctoral research at MIT as postdoctoral associate in the laboratory of Professor Robert Langer.

She joined KFSHRC as an Associate Scientist, first at the Center for Genomic Medicine, and later in the bioenginnering and nanomedicine labs in Innovation & Research. Her current work focuses on biomarker discovery and translation into biomedical technologies advancing healthcare innovation in Saudi Arabia.